![Ramses Erdtmann](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ramses Erdtmann
Founder at BIOMEA FUSION, INC.
Net worth: 22 M $ as of 30/05/2024
Profile
Mr. Rainer M.
Erdtmann is a President, Chief Operating Officer & Director at Biomea Fusion, Inc., a Managing Member at Point Sur Investors LLC, a Managing Director at Oxygen Investments LLC and a President at Biomea Health LLC.
He is on the Board of Directors at Biomea Fusion, Inc.
Prior to forming Point Sur Investors, from 2008-2016, Mr. Erdtmann was with Pharmacyclics, Inc., a Nasdaq-listed biotech company.
He began as Vice President, Finance & Administration, Corporate Secretary and acted as the Principal Financial and Accounting Officer.
In that capacity he was responsible for accounting, SEC reporting, audits, and investor relations.
He built and had operational responsibility for Finance, IT, HR, Legal, Facilities, and Events.
He later served as Executive Vice President of Corporate Affairs including Corporate Communications.
Additionally, he structured and administered the international revenue for Pharmacyclics into a swiss-based subsidiary.
He also actively participated in the final execution of key corporate milestones for Pharmacyclics, among them the Collaboration Agreement with J&J in 2011 (value $1.0 Billion) and the merger agreement with AbbVie in 2015 (value $21 Billion).
Prior to Pharmacyclics, he worked as an asset manager and investment banker, representing European and US institutional investors, family offices and high net worth investors.
He began his career at Commerzbank, Germany, where he was an investment banker and portfolio manager for institutional international accounts.
He earned the Diplom Kaufmann degree, with honors, in Finance and Banking from the Westfaelische Wilhelms Universitaet Muenster, Germany.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
BIOMEA FUSION INC
5.71% | 16/01/2024 | 2,052,030 ( 5.71% ) | 22 M $ | 30/05/2024 |
Ramses Erdtmann active positions
Companies | Position | Start |
---|---|---|
BIOMEA FUSION, INC. | Founder | 31/07/2017 |
Point Sur Investors LLC
![]() Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | Founder | 31/12/2014 |
Biomea Health LLC | Founder | - |
Former positions of Ramses Erdtmann
Companies | Position | End |
---|---|---|
REGENETP, INC. | Director/Board Member | 22/03/2020 |
PHARMACYCLICS, INC. | Director of Finance/CFO | 20/08/2012 |
Oxygen Investments LLC | Founder | 31/12/2008 |
Robert W. Duggan & Associates
![]() Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Corporate Officer/Principal | 31/12/2007 |
Robert W. Duggan & Associates
![]() Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Corporate Officer/Principal | 31/12/2000 |
Training of Ramses Erdtmann
University of Münster | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
REGENETP, INC. | Health Technology |
SUMMIT THERAPEUTICS INC. | Health Technology |
BIOMEA FUSION, INC. | Health Technology |
COMMERZBANK AG | Finance |
Private companies | 8 |
---|---|
United Properties Immobilien & Anlagen GmbH | |
Pharmacyclics LLC
![]() Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Commerz International Capital Management GmbH | |
Robert W. Duggan & Associates
![]() Robert W. Duggan & Associates Investment ManagersFinance Robert W. Duggan & Associates provides investment advisory services. The firm also offers portfolio management, financial planning, and consulting services. The company was founded by Robert W. Duggan and is headquartered in Santa Barbara, CA. | Finance |
Oxygen Investments LLC | |
Point Sur Investors LLC
![]() Point Sur Investors LLC Investment ManagersFinance Point Sur Investors LLC provides investment advice. The private company is based in El Cerrito, CA and has subsidiaries in the United States. The company was founded in 2015 by Thomas Butler, Rainer M. Erdtmann. | Finance |
Summit Therapeutics Ltd.
![]() Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Biomea Health LLC |
- Stock Market
- Insiders
- Ramses Erdtmann